 Hanmant Gaikwad
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 6 | 2025 | 481 | 0.890 |
Why?
| | Complement Inactivating Agents | 2 | 2025 | 63 | 0.850 |
Why?
| | Integrins | 1 | 2023 | 95 | 0.780 |
Why?
| | Fibronectins | 1 | 2023 | 133 | 0.780 |
Why?
| | Complement C3 | 2 | 2023 | 209 | 0.660 |
Why?
| | Click Chemistry | 3 | 2019 | 49 | 0.660 |
Why?
| | Lymphocytes | 1 | 2020 | 397 | 0.570 |
Why?
| | Monocytes | 1 | 2020 | 563 | 0.540 |
Why?
| | Lipids | 2 | 2022 | 672 | 0.480 |
Why?
| | Cell Membrane | 1 | 2019 | 738 | 0.480 |
Why?
| | Liposomes | 5 | 2025 | 223 | 0.470 |
Why?
| | Neutrophils | 1 | 2020 | 1238 | 0.440 |
Why?
| | Polyethylene Glycols | 5 | 2025 | 641 | 0.420 |
Why?
| | Doxorubicin | 3 | 2025 | 362 | 0.410 |
Why?
| | Presbyopia | 2 | 2023 | 15 | 0.400 |
Why?
| | Nanomedicine | 2 | 2025 | 47 | 0.370 |
Why?
| | Lens, Crystalline | 2 | 2023 | 125 | 0.360 |
Why?
| | Fluorescent Dyes | 3 | 2022 | 321 | 0.350 |
Why?
| | Cathepsins | 2 | 2022 | 24 | 0.340 |
Why?
| | Immunoglobulin G | 3 | 2025 | 893 | 0.320 |
Why?
| | Antibodies | 2 | 2019 | 410 | 0.260 |
Why?
| | Rhodiola | 1 | 2025 | 1 | 0.240 |
Why?
| | Single-Domain Antibodies | 1 | 2025 | 15 | 0.240 |
Why?
| | Quinazolinones | 2 | 2015 | 19 | 0.230 |
Why?
| | Caspase 9 | 1 | 2025 | 57 | 0.230 |
Why?
| | Pyrazoles | 3 | 2012 | 423 | 0.210 |
Why?
| | Plant Extracts | 1 | 2025 | 202 | 0.200 |
Why?
| | Receptors, Complement 3d | 1 | 2023 | 141 | 0.200 |
Why?
| | Mice | 12 | 2025 | 17787 | 0.200 |
Why?
| | Immunoglobulin M | 1 | 2024 | 289 | 0.200 |
Why?
| | Crystallins | 1 | 2023 | 59 | 0.190 |
Why?
| | Bone Neoplasms | 1 | 2025 | 247 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 852 | 0.180 |
Why?
| | Apoptosis | 2 | 2025 | 2553 | 0.180 |
Why?
| | Molecular Imaging | 1 | 2022 | 56 | 0.180 |
Why?
| | Ligands | 1 | 2023 | 664 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 1 | 2025 | 557 | 0.170 |
Why?
| | Heterocyclic Compounds, 1-Ring | 1 | 2019 | 5 | 0.160 |
Why?
| | Carbocyanines | 1 | 2019 | 33 | 0.160 |
Why?
| | Cell-Derived Microparticles | 1 | 2020 | 71 | 0.160 |
Why?
| | Tandem Mass Spectrometry | 3 | 2023 | 532 | 0.150 |
Why?
| | Collagen Type II | 1 | 2019 | 53 | 0.150 |
Why?
| | Cathepsin L | 1 | 2019 | 9 | 0.150 |
Why?
| | Cathepsin B | 1 | 2019 | 14 | 0.150 |
Why?
| | Jurkat Cells | 1 | 2019 | 134 | 0.150 |
Why?
| | Biological Transport | 1 | 2020 | 418 | 0.150 |
Why?
| | Color | 1 | 2019 | 76 | 0.150 |
Why?
| | Cyclooctanes | 1 | 2018 | 5 | 0.150 |
Why?
| | Piperazines | 2 | 2012 | 350 | 0.150 |
Why?
| | Bone Marrow | 1 | 2020 | 286 | 0.150 |
Why?
| | Glioblastoma | 1 | 2022 | 345 | 0.150 |
Why?
| | Animals | 13 | 2025 | 36940 | 0.140 |
Why?
| | Anti-Inflammatory Agents | 2 | 2019 | 496 | 0.130 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 365 | 0.130 |
Why?
| | Protein Binding | 1 | 2023 | 2224 | 0.130 |
Why?
| | Glioma | 1 | 2021 | 395 | 0.130 |
Why?
| | Quinones | 1 | 2015 | 9 | 0.120 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2015 | 52 | 0.120 |
Why?
| | Carbazoles | 1 | 2015 | 83 | 0.110 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2012 | 180 | 0.110 |
Why?
| | Drug Design | 1 | 2015 | 167 | 0.110 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 201 | 0.110 |
Why?
| | Pyrroles | 1 | 2015 | 213 | 0.110 |
Why?
| | Erythrocytes | 1 | 2019 | 700 | 0.100 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2015 | 210 | 0.100 |
Why?
| | Histone Deacetylases | 1 | 2015 | 215 | 0.100 |
Why?
| | Brain Neoplasms | 1 | 2022 | 1238 | 0.100 |
Why?
| | Disulfides | 2 | 2023 | 107 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2253 | 0.100 |
Why?
| | Solubility | 2 | 2023 | 245 | 0.100 |
Why?
| | Humans | 15 | 2025 | 137585 | 0.090 |
Why?
| | Complement Activation | 2 | 2025 | 415 | 0.090 |
Why?
| | Chromatography, Liquid | 2 | 2023 | 433 | 0.090 |
Why?
| | Macrophages | 1 | 2019 | 1547 | 0.090 |
Why?
| | Amides | 1 | 2011 | 93 | 0.090 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3412 | 0.090 |
Why?
| | Imidazoles | 1 | 2012 | 238 | 0.090 |
Why?
| | Lipase | 1 | 2011 | 69 | 0.080 |
Why?
| | Carboxylic Acids | 1 | 2010 | 34 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2019 | 1996 | 0.080 |
Why?
| | Arthritis, Rheumatoid | 1 | 2019 | 1167 | 0.080 |
Why?
| | Molecular Structure | 3 | 2018 | 489 | 0.080 |
Why?
| | Quinolines | 1 | 2011 | 178 | 0.080 |
Why?
| | Water | 2 | 2023 | 460 | 0.080 |
Why?
| | Flow Cytometry | 2 | 2025 | 1178 | 0.080 |
Why?
| | Bone Marrow Cells | 2 | 2020 | 316 | 0.070 |
Why?
| | Rats | 3 | 2025 | 5647 | 0.070 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 350 | 0.070 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1272 | 0.060 |
Why?
| | Ferric Compounds | 1 | 2025 | 56 | 0.060 |
Why?
| | Dogs | 1 | 2025 | 413 | 0.050 |
Why?
| | Receptors, Complement 3b | 1 | 2023 | 84 | 0.050 |
Why?
| | Down-Regulation | 1 | 2025 | 657 | 0.050 |
Why?
| | Acetylation | 1 | 2023 | 248 | 0.050 |
Why?
| | Dextrans | 1 | 2022 | 84 | 0.050 |
Why?
| | Structure-Activity Relationship | 2 | 2015 | 570 | 0.050 |
Why?
| | NIH 3T3 Cells | 1 | 2022 | 144 | 0.050 |
Why?
| | Endothelium | 1 | 2022 | 123 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 1 | 2023 | 665 | 0.040 |
Why?
| | Lysine | 1 | 2023 | 294 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2011 | 194 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2021 | 325 | 0.040 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2020 | 81 | 0.040 |
Why?
| | Phospholipids | 1 | 2021 | 223 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2021 | 402 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2011 | 2129 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 50 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2015 | 2057 | 0.040 |
Why?
| | Mitochondrial Dynamics | 1 | 2019 | 39 | 0.040 |
Why?
| | Models, Molecular | 2 | 2015 | 1570 | 0.040 |
Why?
| | Drug Carriers | 1 | 2018 | 128 | 0.030 |
Why?
| | Cartilage | 1 | 2019 | 188 | 0.030 |
Why?
| | Surface Properties | 1 | 2018 | 413 | 0.030 |
Why?
| | Arthritis, Experimental | 1 | 2019 | 147 | 0.030 |
Why?
| | Particle Size | 1 | 2018 | 394 | 0.030 |
Why?
| | Cholesterol | 1 | 2019 | 410 | 0.030 |
Why?
| | Autophagy | 1 | 2019 | 284 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2019 | 622 | 0.030 |
Why?
| | Histone Deacetylase 2 | 1 | 2015 | 10 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2019 | 739 | 0.030 |
Why?
| | Histone Deacetylase 1 | 1 | 2015 | 25 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2015 | 90 | 0.030 |
Why?
| | K562 Cells | 1 | 2015 | 89 | 0.030 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2015 | 51 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2015 | 124 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2015 | 114 | 0.030 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2015 | 67 | 0.030 |
Why?
| | HeLa Cells | 1 | 2015 | 636 | 0.030 |
Why?
| | Aged | 2 | 2023 | 23961 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2015 | 189 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 327 | 0.020 |
Why?
| | Mitochondria | 1 | 2019 | 948 | 0.020 |
Why?
| | Deuterium Exchange Measurement | 1 | 2012 | 30 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2023 | 5757 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2019 | 1317 | 0.020 |
Why?
| | Methanol | 1 | 2012 | 38 | 0.020 |
Why?
| | Cell Cycle | 1 | 2015 | 601 | 0.020 |
Why?
| | Proteomics | 1 | 2019 | 1111 | 0.020 |
Why?
| | Cations | 1 | 2012 | 84 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3015 | 0.020 |
Why?
| | Carrageenan | 1 | 2011 | 8 | 0.020 |
Why?
| | Stereoisomerism | 1 | 2011 | 96 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4193 | 0.020 |
Why?
| | Biocatalysis | 1 | 2011 | 56 | 0.020 |
Why?
| | Candida | 1 | 2011 | 38 | 0.020 |
Why?
| | Female | 3 | 2025 | 73304 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2015 | 528 | 0.020 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2010 | 86 | 0.020 |
Why?
| | Edema | 1 | 2011 | 130 | 0.020 |
Why?
| | Male | 3 | 2024 | 67762 | 0.020 |
Why?
| | Neoplasms | 1 | 2024 | 2671 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4295 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2010 | 611 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2011 | 2475 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 33479 | 0.010 |
Why?
| | Adult | 1 | 2024 | 37929 | 0.010 |
Why?
|
|
Gaikwad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|